Interpace Diagnostics Group Inc is engaged in developing and commercializing molecular diagnostic tests, leveraging the latest technology and personalized medicine for diagnosis and management.
| Website: | www.interpacediagnostics.com |
| Email: | mcarey@rxir.com |
| Main Phone: | +1 855 776-6419 |
| Address: | 300 Interpace Parkway |
| Address 2: | Building C |
| State: | NJ |
| City / Town: | Parsippany |
| Country: | USA |
| Postal Code: | 07054 |
| Exchange: | NSC |
| CEO: | Jack E. Stover |
| Employees: | 75 |
| NAICS: | Testing Laboratories(541380) |
| Last Price 1.60 | Change $ 0.07 | Change % 4.58 | Tick N/A |
| Bid 1.60 | Bid Size 600.00 | Ask 1.68 | Ask Size 100.00 |
| Open 1.56 | High 1.65 | Low 1.52 | Prev Close 1.53 |
| Last Trade | Volume 641,980 | 52 Wk Hi 1.80 | 52 Wk Low 0.77 |
| Market Cap 45.1 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 28,194,275.00 | EPS (TTM) -0.51 | PE Ratio N/A | Exchange NCM |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 0 | 7 |
| Number of Buys | 0 | 7 |
| Number of Sells | 0 | 0 |
| Net Activity | 0 | 114400 |
| Last 10 Buys | Shares |
|---|---|
| Graham G. Miao | 1,000 |
| Graham G. Miao | 1,000 |
| Nancy Lurker | 1,000 |
| Gerald R. Melillo | 1,000 |
| Nancy Lurker | 1,000 |
| Jeffrey E. Smith | 1,000 |
| Jeffrey E. Smith | 1,000 |
| Nancy Lurker | 1,000 |
| Nancy Lurker | 1,000 |
| Nancy Lurker | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Gerald R. Melillo | 1,000 |
| Gerald R. Melillo | 1,000 |
| Gerald R. Melillo | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 4.5 | 4.5 | 4.5 | 4.5 |
| Low Target Price Estimate | 3 | 3 | 3 | 3 |
| Mean Target Price Estimate | 3.5 | 3.5 | 3.5 | 3.5 |
| Standard Deviation | 0.87 | 0.87 | 0.87 | 0.87 |
| Date of Most Recent Estimate | 05/16/18 | 05/16/18 | 05/16/18 | 05/16/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 8-K | Report of unscheduled material events or corporate changes. | 4 | 2018-06-14 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 60 | 2018-05-15 |
| 8-K | Report of unscheduled material events or corporate changes. | 13 | 2018-05-15 |
| 8-K | Report of unscheduled material events or corporate changes. | 4 | 2018-05-07 |
| S-8 | Securities offered to employees under employee benefit plans | 12 | 2018-04-30 |
| DEF 14A | Official notification to shareholders of matters to be brought to a vote (Proxy) | 31 | 2018-04-30 |
| 3 | Initial statement of beneficial ownership of securities | 1 | 2018-04-11 |
| 10-K | Annual report with a comprehensive overview of the company | 132 | 2018-03-23 |
| 8-K | Report of unscheduled material events or corporate changes. | 14 | 2018-03-15 |
| 8-K | Report of unscheduled material events or corporate changes. | 4 | 2018-03-13 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
